EUVIMEDEUVIMED entdecken
Open Access

A Robust Ensemble Machine Learning Approach for Inhibitor Discovery: Case Study of HIV‐1 NNRTI and Validation Using MD Simulation

Anvesha Shree, Pratyush Pani, Malay Kumar Rana iD

Chemistry – An Asian Journal · 2026

DOI: 10.1002/asia.70340 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – An Asian Journal, 2026. Verfasst von Anvesha Shree und 2 weiteren Autor:innen. Beteiligte Einrichtung: Physical and Biomolecular Research Lab, Department of Chemical Sciences, Indian Institute of Science Education and Research (IISER) Berhampur, Ganjam…. Hauptthemen laut MEDLINE: Machine Learning, Molecular Dynamics Simulation, HIV Reverse Transcriptase, Reverse Transcriptase Inhibitors. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The growing demand for new therapeutics highlights the need for intelligent, cost‐effective, and scalable drug discovery strategies. Here, we present an artificial intelligence (AI)‐based ensemble framework to accelerate the identification of small‐molecule inhibitors against therapeutic targets. As a case study, we applied this approach to HIV‐1 reverse transcriptase (HIV‐1 RT), an essential enzyme in viral replication. Our stacking ensemble model, trained on a curated ChEMBL dataset, achieved high predictive performance (90.3% accuracy, 89.4% ROC‐AUC) and was used to screen the Natural Products Atlas (NPA) database. Promising hits were evaluated through physicochemical and ADMET filters, molecular docking, and 1 µs molecular dynamics (MD) simulations. Compound NP1, which exhibited stable binding to the NNRTI binding pocket, outperformed the FDA‐approved drug doravirine in post‐MD characterizations. Network analysis further suggested potential allosteric regulation via residues N136 and E138. This flexible AI‐MD pipeline provides an efficient strategy for discovering and repurposing inhibitors, with broad applicability to other therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Machine LearningMolecular Dynamics SimulationHIV Reverse TranscriptaseReverse Transcriptase InhibitorsDrug DiscoveryHIV-1Anti-HIV AgentsHumansMolecular Docking SimulationMolecular Structure

Stichwörter der Autor:innen

EnsembleHIV‐1MD SimulationMachine LearningNNRTI

Substanzen

HIV Reverse TranscriptaseReverse Transcriptase Inhibitorsreverse transcriptase, Human immunodeficiency virus 1Anti-HIV Agents

Autor:innen und Institutionen

  • Physical and Biomolecular Research Lab, Department of Chemical Sciences, Indian Institute of Science Education and Research (IISER) Berhampur, Ganjam, Odisha, 760010, India.
  • Department of Biological Sciences, Indian Institute of Science Education and Research (IISER) Berhampur, Ganjam, Odisha, 760010, India.

ORCID-Profile: Malay Kumar Rana

Zitieren

APA

Shree, A., Pani, P., & Rana, M. K. (2026). A Robust Ensemble Machine Learning Approach for Inhibitor Discovery: Case Study of HIV‐1 NNRTI and Validation Using MD Simulation. Chemistry – An Asian Journal. https://doi.org/10.1002/asia.70340

Vancouver

Shree A, Pani P, Rana MK. A Robust Ensemble Machine Learning Approach for Inhibitor Discovery: Case Study of HIV‐1 NNRTI and Validation Using MD Simulation. Chemistry – An Asian Journal. 2026. doi:10.1002/asia.70340

BibTeX
@article{Shree2026,
  author = {Shree, Anvesha and Pani, Pratyush and Rana, Malay Kumar},
  title = {A Robust Ensemble Machine Learning Approach for Inhibitor Discovery: Case Study of HIV‐1 NNRTI and Validation Using MD Simulation},
  journal = {Chemistry – An Asian Journal},
  year = {2026},
  doi = {10.1002/asia.70340}
}
Kostenlos starten →